+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904903
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Immunoassay Market grew from USD 26.30 billion in 2023 to USD 28.29 billion in 2024. It is expected to continue growing at a CAGR of 7.24%, reaching USD 42.90 billion by 2030.

The growth of the immunoassay market can be attributed to several influencing factors, such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, expanding use of immunoassays in oncology diagnostics, and advancements in technology leading to higher throughput capabilities with improved accuracy. Moreover, the COVID-19 pandemic has also contributed significantly to the growth of this market due to the surge in demand for rapid testing solutions. However, high costs associated with advanced immunoassay systems may hamper their adoption by smaller laboratories or resource-limited settings. Additionally, stringent regulatory guidelines regarding product approvals can prolong the time to market for new products. To overcome these challenges and sustain business growth in the immunoassay market, organizations are exploring potential areas of innovation and research, including focusing on R&D efforts to create cost-effective solutions that cater to a wider user base across different healthcare settings worldwide. Additionally, collaborating with academic institutions and research centers to foster breakthrough innovations in assay design, targeting novel analytes or applications not currently addressed by existing products. Along with these, market participants are developing novel biomarkers for the early detection of diseases, leading to an expansion in clinical applications of immunoassays.

Regional Insights

In the Americas, the United States and Canada have witnessed a growing demand for immunoassays due to a rising prevalence of chronic diseases such as cancer and cardiovascular disorders. Increasing healthcare spending in these countries has also supplemented increased focus on early detection of diseases; laboratories are investing heavily in advanced technologies such as enzyme-linked immunosorbent assays (ELISA) and chemiluminescence immunoassays (CLIA). Apart from these, recent patents filed in this region encompass improvements in assay sensitivity and specificity while reducing cross-reactivity issues. In EU countries, the Middle East and Africa region has seen significant growth in the immunoassay market due to rising consumer health awareness. Initiatives led by governments and healthcare organizations have bolstered public investment in diagnostic services. Key players in this market focus on developing new products catering to specific regional customer requirements. Emerging countries across the Asia Pacific, such as India and China, present a considerable growth opportunity for immunoassay manufacturers due to increasing healthcare expenditure, rising prevalence of chronic diseases requiring diagnostic testing services, improving laboratory infrastructure, and growing awareness about early disease detection. Furthermore, customizing products to cater to specific disease patterns in emerging markets has helped expand key profiles. Additionally, the regional government has launched several initiatives to promote public-private partnerships in developing innovative diagnostic methods, providing support and investment for academic institutions and private enterprises.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Immunoassay Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising chronic and infectious diseases and benefits of early diagnosis
  • Growing usage of immunoassay in the food & beverage sector
  • Emerging application of multiplex detection immunoassay technique in drug development

Market Restraints

  • Cross-reactivity issues associated with immunoassay

Market Opportunities

  • Technological advancements in the number of automated instruments and equipment associated with immunoassay
  • High potential of immunoassay in environment monitoring

Market Challenges

  • Issues with assay validation due to variations in sample quality and reagent performance

Market Segmentation Analysis

  • Product: Development of novel immunoassay kits for diagnostics of infectious and autoimmune diseases
  • Technology: Utilization of enzyme-linked immunosorbent assay technology for food allergies and drugs of abuse treatment
  • Specimen: Emergence of saliva diagnostics due to its non-invasive collection methods
  • Indication: Optimization within immunoassay technologies to cater growing need across infectious disease
  • End User: Rising demand for immunoassay across emergency care, intensive care units, and outpatient clinics

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Immunoassay Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Immunoassay Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Thermo Fisher to Acquire Olink for USD 3.1 billion, Expanding Proteomics Presence

Thermo Fisher Scientific, Inc. has acquired Olink Holding for approximately USD 3.1 billion to enhance its presence in proteomics. The acquisition of Olink underscores the profound impact of proteomics as Thermo Fisher's customers continue to advance life science research and precision medicine.

Fujirebio and Sysmex to Collaborate On Development of Unique Immunoassays

Fujirebio Holdings, Inc. and Sysmex Corporation expanded their partnership in immunoassay tests. This partnership encompasses various areas such as research, manufacturing, clinical development, and sales and marketing.

Mindray Has Agreed to Acquire 75% Stake in Germany-Based DiaSys Diagnostic Systems GmbH

Mindray acquired a 75% equity interest in DiaSys Diagnostic Systems GmbH from Gorka Holding GmbH for approximately Euro 115 million. This acquisition enhanced Mindray's overseas supply chain platform and facilitated penetration into medium to large customer segments. By acquiring DiaSys, Mindray aims to strengthen its position in the market, delivering innovative solutions and high-quality products to meet the growing needs of healthcare professionals and patients worldwide.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Immunoassay Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Immunoassay Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Almac Group Limited, ANP Technologies, Inc., Autobio Diagnostics Co., Ltd., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc., bioMérieux S.A., Biosurfit SA, Boditech Med Inc., Charles River Laboratories International, Inc., Danaher Corporation, Diasorin S.p.A., Dynex Technologies, Inc., Epitope Diagnostics Inc., F. Hoffmann-La Roche Ltd., Fapon Biotech Inc., Gyros Protein Technologies AB, H.U. Group Holdings Inc., J. Mitra & Co. Pvt. Ltd., Kamiya Biomedical Company, Koninklijke Philips N.V., Merck KGaA, MiCo BioMed, Inc., NanoEntek, Nanōmix, Inc., OPKO Health, Inc., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Quanterix Corporation, QuidelOrtho Corporation, Randox Laboratories Ltd., Shenzhen Micropoint Biotechnologies Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Sysmex Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Tosoh Corporation, WAK-Chemie Medical GmbH, Zoetis Inc., and Zybio Inc..

Market Segmentation & Coverage

This research report categorizes the Immunoassay Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Analyzer

Consumables

  • Assay Kits
  • Microwell Plates & Tubes
  • Reagents

Technology

  • Chemiluminescence Immunoassay
  • Enzyme-linked Immunosorbent Assay
  • Fluoroimmunoassay
  • Radioimmunoassay
  • Rapid Diagnostic Tests (RDTs)/Lateral Flow Immunoassay

Specimen

  • Blood
  • Saliva
  • Urine

Indication

  • Cardiology
  • Endocrinology
  • Infectious Disease
  • Oncology
  • Orthopedics

End User

  • Blood Banks
  • Diagnostics Laboratories
  • Food & Beverage Companies
  • Hospitals
  • Pharmaceutical Companies & CROs
  • Research & Academic Laboratories

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising chronic and infectious diseases and benefits of early diagnosis
5.1.1.2. Growing usage of immunoassay in the food & beverage sector
5.1.1.3. Emerging application of multiplex detection immunoassay technique in drug development
5.1.2. Restraints
5.1.2.1. Cross-reactivity issues associated with immunoassay
5.1.3. Opportunities
5.1.3.1. Technological advancements in the number of automated instruments and equipment associated with immunoassay
5.1.3.2. High potential of immunoassay in environment monitoring
5.1.4. Challenges
5.1.4.1. Issues with assay validation due to variations in sample quality and reagent performance
5.2. Market Segmentation Analysis
5.2.1. Product: Development of novel immunoassay kits for diagnostics of infectious and autoimmune diseases
5.2.2. Technology: Utilization of enzyme-linked immunosorbent assay technology for food allergies and drugs of abuse treatment
5.2.3. Specimen: Emergence of saliva diagnostics due to its non-invasive collection methods
5.2.4. Indication: Optimization within immunoassay technologies to cater growing need across infectious disease
5.2.5. End User: Rising demand for immunoassay across emergency care, intensive care units, and outpatient clinics
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Regulatory Framework Analysis
6. Immunoassay Market, by Product
6.1. Introduction
6.2. Analyzer
6.3. Consumables
7. Immunoassay Market, by Technology
7.1. Introduction
7.2. Chemiluminescence Immunoassay
7.3. Enzyme-linked Immunosorbent Assay
7.4. Fluoroimmunoassay
7.5. Radioimmunoassay
7.6. Rapid Diagnostic Tests (RDTs)/Lateral Flow Immunoassay
8. Immunoassay Market, by Specimen
8.1. Introduction
8.2. Blood
8.3. Saliva
8.4. Urine
9. Immunoassay Market, by Indication
9.1. Introduction
9.2. Cardiology
9.3. Endocrinology
9.4. Infectious Disease
9.5. Oncology
9.6. Orthopedics
10. Immunoassay Market, by End User
10.1. Introduction
10.2. Blood Banks
10.3. Diagnostics Laboratories
10.4. Food & Beverage Companies
10.5. Hospitals
10.6. Pharmaceutical Companies & CROs
10.7. Research & Academic Laboratories
11. Americas Immunoassay Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Immunoassay Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Immunoassay Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Thermo Fisher to Acquire Olink for USD 3.1 billion, Expanding Proteomics Presence
14.3.2. Fujirebio and Sysmex to Collaborate On Development of Unique Immunoassays
14.3.3. Mindray Has Agreed to Acquire 75% Stake in Germany-Based DiaSys Diagnostic Systems GmbH
14.3.4. CVC Fund “Shimadzu Future Innovation Fund” has Invested in IMMUNOSENS Co., Ltd., Developing Immunoassay Technology.
14.3.5. Fapon Rolls Out New Chemiluminescence Immunoassay System
14.3.6. Beckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
14.3.7. Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer’s Disease Test
14.3.8. MakatiMed First PH and ASEAN Hospital to Acquire Atellica VTLi Patient-Side Immunoassay Analyzer
14.3.9. QuidelOrtho Receives De Novo FDA Authorization for Sofia 2 SARS Antigen+ FIA
14.3.10. SGS Offers Enhanced Automated Immunoassay Testing at Poitiers Laboratory
14.3.11. Siemens launches Centre of Excellence for Immunoassay Instrument R&D
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. IMMUNOASSAY MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOASSAY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOASSAY MARKET DYNAMICS
FIGURE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2023 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL IMMUNOASSAY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROWELL PLATES & TUBES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROWELL PLATES & TUBES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROIMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROIMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOASSAY MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS)/LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL IMMUNOASSAY MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS)/LATERAL FLOW IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNOASSAY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL IMMUNOASSAY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNOASSAY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL IMMUNOASSAY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL COMPANIES & CROS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL COMPANIES & CROS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 105. CANADA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. CANADA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. CANADA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 108. CANADA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 109. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 110. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 111. CANADA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 112. CANADA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 113. CANADA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 114. CANADA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 115. CANADA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 116. CANADA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 117. MEXICO IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. MEXICO IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. MEXICO IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 120. MEXICO IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 121. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 122. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 123. MEXICO IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 124. MEXICO IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 125. MEXICO IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 126. MEXICO IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 127. MEXICO IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 128. MEXICO IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 136. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 150. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 152. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 160. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 161. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 164. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 165. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 166. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 167. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 168. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 169. CHINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. CHINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. CHINA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 172. CHINA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 173. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 174. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 175. CHINA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 176. CHINA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 177. CHINA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 178. CHINA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 179. CHINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 180. CHINA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 181. INDIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. INDIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. INDIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 184. INDIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 185. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 186. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 187. INDIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 188. INDIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 189. INDIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 190. INDIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 191. INDIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 192. INDIA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 193. INDONESIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. INDONESIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. INDONESIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 196. INDONESIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 197. INDONESIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 198. INDONESIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 199. INDONESIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 200. INDONESIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 201. INDONESIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 202. INDONESIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 203. INDONESIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 204. INDONESIA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 205. JAPAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. JAPAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. JAPAN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 208. JAPAN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 209. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. JAPAN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 212. JAPAN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 213. JAPAN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. JAPAN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. JAPAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 216. JAPAN IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 217. MALAYSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. MALAYSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. MALAYSIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 220. MALAYSIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 221. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. MALAYSIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 224. MALAYSIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 225. MALAYSIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 226. MALAYSIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 227. MALAYSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 228. MALAYSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 229. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 232. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 233. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 234. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 235. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 236. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 237. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 238. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 239. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 240. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 241. SINGAPORE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. SINGAPORE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. SINGAPORE IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 244. SINGAPORE IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 245. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 246. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 247. SINGAPORE IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 248. SINGAPORE IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 249. SINGAPORE IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 250. SINGAPORE IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 251. SINGAPORE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 252. SINGAPORE IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 253. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 256. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 257. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 258. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 259. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 260. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 261. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 262. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 263. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 264. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 265. TAIWAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. TAIWAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. TAIWAN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 268. TAIWAN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 269. TAIWAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 270. TAIWAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 271. TAIWAN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 272. TAIWAN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 273. TAIWAN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 274. TAIWAN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 275. TAIWAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 276. TAIWAN IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 277. THAILAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. THAILAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. THAILAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 280. THAILAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 281. THAILAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 282. THAILAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 283. THAILAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 284. THAILAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 285. THAILAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 286. THAILAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 287. THAILAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 288. THAILAND IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 289. VIETNAM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. VIETNAM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. VIETNAM IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 292. VIETNAM IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 293. VIETNAM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 294. VIETNAM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 295. VIETNAM IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 296. VIETNAM IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 297. VIETNAM IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 298. VIETNAM IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 299. VIETNAM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 300. VIETNAM IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 315. DENMARK IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. DENMARK IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. DENMARK IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 318. DENMARK IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 319. DENMARK IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 320. DENMARK IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 321. DENMARK IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 322. DENMARK IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 323. DENMARK IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 324. DENMARK IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 325. DENMARK IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 326. DENMARK IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 327. EGYPT IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 328. EGYPT IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 329. EGYPT IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 330. EGYPT IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 331. EGYPT IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 332. EGYPT IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 333. EGYPT IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 334. EGYPT IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 335. EGYPT IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 336. EGYPT IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 337. EGYPT IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 338. EGYPT IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 339. FINLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 340. FINLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 341. FINLAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 342. FINLAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 343. FINLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 344. FINLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 345. FINLAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 346. FINLAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 347. FINLAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 348. FINLAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 349. FINLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 350. FINLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 351. FRANCE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 352. FRANCE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 353. FRANCE IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 354. FRANCE IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 355. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 356. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 357. FRANCE IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 358. FRANCE IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 359. FRANCE IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 360. FRANCE IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 361. FRANCE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 362. FRANCE IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 363. GERMANY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 364. GERMANY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 365. GERMANY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 366. GERMANY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 367. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 368. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 369. GERMANY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 370. GERMANY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 371. GERMANY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 372. GERMANY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 373. GERMANY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 374. GERMANY IMMUNOASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 375. ISRAEL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 376. ISRAEL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 377. ISRAEL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 378. ISRAEL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 379. ISRAEL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 380. ISRAEL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 381. ISRAEL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2023 (USD MILLION)
TABLE 382. ISRAEL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2024-2030 (USD MILLION)
TABLE 383. ISRAEL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 384. ISRAEL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 385. ISRAEL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 386. ISRAEL IMMUNOASSAY

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Almac Group Limited
  • ANP Technologies, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • bioMérieux S.A.
  • Biosurfit SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Diasorin S.p.A.
  • Dynex Technologies, Inc.
  • Epitope Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fapon Biotech Inc.
  • Gyros Protein Technologies AB
  • H.U. Group Holdings Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Kamiya Biomedical Company
  • Koninklijke Philips N.V.
  • Merck KGaA
  • MiCo BioMed, Inc.
  • NanoEntek
  • Nanōmix, Inc.
  • OPKO Health, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quanterix Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • WAK-Chemie Medical GmbH
  • Zoetis Inc.
  • Zybio Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 28.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 42.9 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal

Related Topics

Related Reports

Global Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagent & Kits, Analyzers/Instruments), Technology (RIA, ELISA), Application, Specimen, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagent & Kits, Analyzers/Instruments), Technology (RIA, ELISA), Application, Specimen, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Software & Services), Application (Oncology, Cardiology), Specimen, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Software & Services), Application (Oncology, Cardiology), Specimen, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Global Immunoassay Analyzers Market by Product (Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay), Application (Autoimmune Disease, Cardiology, Endocrinology) - Forecast 2024-2030 - Product Image

Global Immunoassay Analyzers Market by Product (Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay), Application (Autoimmune Disease, Cardiology, Endocrinology) - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Global Chemiluminescence Immunoassay Analyzers Market by Product (Analyzers, Consumables, Reagents), End-User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Industries), Application - Forecast 2024-2030 - Product Image

Global Chemiluminescence Immunoassay Analyzers Market by Product (Analyzers, Consumables, Reagents), End-User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Industries), Application - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Rapid Tests), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Blood Banks) & Region - Global Forecast to 2028 - Product Image

Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Rapid Tests), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Blood Banks) & Region - Global Forecast to 2028

  • Report
  • 382 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.